SRES 531 is a non-binding Senate resolution celebrating the 50th anniversary of the Individuals with Disabilities Education Act (IDEA) on November 29, 2025. It recognizes IDEA's historical role in guaranteeing children with disabilities access to free appropriate public education in inclusive settings, transforming educational opportunities for millions. The resolution honors students, families, educators, and advocates who advanced IDEA's principles since its 1975 enactment. It does not create new policy but formally acknowledges the law's enduring impact on educational equity.
HRES 926, the RESPECT Resolution, is a non-binding House resolution urging states to adopt equity-focused cannabis policies. It recommends specific actions to address racial disparities, including eliminating criminal penalties for cannabis possession, creating fairer business licensing (prioritizing communities harmed by past enforcement), automatically expunging cannabis convictions, and reinvesting tax revenue in affected communities. The resolution also calls for the U.S. to advocate at the United Nations for cannabis descheduling from international drug treaties. It directly affects states, localities, and communities disproportionately impacted by cannabis prohibition, particularly communities of color.
HRES 930 is a symbolic resolution designating December 8, 2025, as "Jimmy Lai Day" to honor Jimmy Lai's advocacy for free press, religious freedom, and democracy in Hong Kong. It calls on the People's Republic of China and Hong Kong authorities to release Jimmy Lai and other Hong Kong prodemocracy advocates detained under Hong Kong's National Security Law. The resolution does not create new laws or policies but expresses congressional support for Lai's work and condemns the imprisonment of those advocating for Hong Kong's freedoms. It directly affects U.S. diplomatic messaging toward China, not Hong Kong's legal system or residents.
The Restoring Patient Protections and Affordability Act of 2025 extends enhanced premium tax credits through 2028, making health insurance more affordable for lower- and middle-income individuals. It extends the 2026 open enrollment period through May 1, 2026, and restores funding for navigator programs that help people enroll in health insurance plans. The bill requires health insurance issuers to notify enrollees about changes to premium assistance and establishes $1,000 daily penalties for failing to comply with these notification requirements. Additionally, it limits surprise premium increases for people with household incomes below 400% of the poverty line and prevents premium spikes for those with ACA or employer coverage. These changes directly affect millions of people enrolled in health insurance plans through the Affordable Care Act marketplaces.
The Medicare-X Choice Act of 2025 would establish a new public health insurance option called the "Medicare Exchange health plan" available through health insurance exchanges starting in 2028 for eligible individuals who are not enrolled in traditional Medicare. The plan would offer silver and gold coverage levels with no cost-sharing for primary care services, and would reimburse healthcare providers at Medicare rates. Healthcare providers enrolled in Medicare or Medicaid would be required to participate in this public plan, and the bill includes provisions to collect data addressing health disparities and improve care coordination. The plan would be funded through $1 billion in appropriations for each of two funds to establish and administer the program, while maintaining existing Medicare benefits and trust funds.
S 3346, the Freedom to Heal Act of 2025, creates a new registration process for physicians to administer Schedule I investigational drugs under the federal Right to Try program. It directly affects physicians who wish to treat eligible patients with these experimental drugs by requiring them to apply to the Attorney General with specific documentation, including manufacturer agreements and proof of state compliance. Key provisions include a 45-day approval timeline for applications, limits on drug quantities based on submitted requests, and requirements for secure storage and record-keeping. The bill mandates the Attorney General to issue interim rules within 240 days to implement these registration standards, focusing on preventing diversion while enabling patient access.
S 3347, the Flight Delay and Cancellation Compensation Act, requires airlines to provide $750 in cash compensation, free rebooking, meals, and for overnight delays, lodging and transportation when flights are delayed or canceled due to the airline's fault. The bill mandates the Transportation Secretary to form a committee within 90 days - including airline, airport, and consumer representatives - to develop recommendations for these standards, including aligning with international rules like Canada's Air Passenger Protection Regulations. An interim rule implementing these requirements will take effect two years after enactment, mandating the compensation and services for affected passengers. This legislation standardizes passenger protections across U.S. airlines to align with global practices.
This bill prohibits U.S. military action against Venezuela without specific new congressional authorization. It blocks funding for Defense Department operations involving "hostilities" (defined as any use of lethal force by U.S. forces) except under two conditions: a new law passed after this bill's enactment, or a congressional authorization meeting War Powers Resolution standards. Key exceptions allow self-defense, protection of U.S. personnel, lawful counternarcotics operations, and humanitarian aid. The bill does not override the War Powers Resolution but requires stricter authorization for military engagement with Venezuela.
The SAFE Chips Act of 2025 requires U.S. exporters to obtain government licenses before sending advanced computer chips to "foreign adversary countries" (including China, Hong Kong, and Macau) or to entities owned by such countries. It defines "advanced integrated circuits" using specific technical standards, such as high processing power (e.g., 4,800+ performance points) or bandwidth (e.g., 4,100+ gigabytes per second), excluding chips designed for data centers. The bill mandates license denials for these exports and allows the Commerce Secretary to update technical definitions after 30 months, with required Congressional briefings on national security impacts. This directly affects chip manufacturers and companies exporting to specified regions, imposing strict controls on advanced semiconductor trade.
This bill updates the Social Security lump sum death payment amount from a formula based on the deceased's benefit to a fixed $2,900. The payment will automatically increase each year starting in 2026 based on the Consumer Price Index (CPI), ensuring it keeps pace with inflation. It directly affects survivors who receive the lump sum death payment following a Social Security recipient's death. The change applies to deaths occurring on or after January 1, 2026, replacing the previous "three times" calculation method.
HR 6475, the Preventing Child Trafficking Act of 2025, requires the Department of Justice's Office for Victims of Crime and the Administration for Children and Families' Office on Trafficking in Persons to implement the 2023 Government Accountability Office's recommendations for preventing child trafficking and supporting survivors. The bill mandates these agencies to collaborate using established best practices, develop measurable performance goals for child trafficking programs, and base these targets on existing grantee data. It directly affects federal agencies managing anti-trafficking programs and the children and survivors served by those programs. The bill requires a report to Congress within 180 days detailing how these implementation steps were carried out.
HR 6466, the Forced Abortion Prevention and Accountability Act, prohibits non-consensual administration of abortion drugs (like mifepristone or misoprostol) to pregnant women without their informed consent. It criminalizes this act with penalties up to 25 years in prison and allows victims to sue for triple damages, psychological/physical injury compensation, and attorney fees. The bill directly affects pregnant women who might face coerced procedures and medical providers or others who administer such drugs without consent. Key provisions include criminal penalties for the act itself, enhanced penalties for serious injury or death, and a civil remedy framework for victims seeking compensation.
